Clinical Trial Update: Aflibercept +/- LV5FU2 in First Line of Non-resectalbe Metastatic Colorectal Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating aflibercept with or without LV5FU2 as first-line therapy for non-resectable metastatic colorectal cancer has completed and results have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Leucovorin + 5-fluorouracil (Leucovorin + 5-FU)
• Zaltrap (ramucirumab)

Snippet

Sponsor: Federation Francophone de Cancerologie Digestive | Conditions: Colorectal Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2024-07-10